α7-Nicotinic acetylcholine receptors mediate an Aβ 1-42-induced increase in the level of acetylcholinesterase in primary cortical neurones

Journal of Neurochemistry

Volumn 88, Issue 5, 2004, Pages 1186-1193

  Fodero, L R ^a,b   Mok, S S ^a,b   Losic, D ^b,c   Martin, L L ^b   Aguilar, M I ^b   Barrow, C J ^a   Livett, B G ^a   Small, David H ^b  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b MONASH UNIVERSITY   (Australia)

^c FLINDERS UNIVERSITY   (Australia)

Author keywords

Acetylcholinesterase; Alzheimer's disease; Amyloid; Cholinergic; Nicotinic

Indexed keywords

ACETYLCHOLINESTERASE; AMYLOID BETA PROTEIN; AMYLOID BETA PROTEIN[1-40]; AMYLOID BETA PROTEIN[1-42]; BUNGAROTOXIN RECEPTOR; CALCIUM CHANNEL BLOCKING AGENT; CALCIUM CHANNEL L TYPE; CALCIUM CHANNEL N TYPE; CHOLINE; NICOTINE; NICOTINIC AGENT; NICOTINIC RECEPTOR; NICOTINIC RECEPTOR BLOCKING AGENT; UNCLASSIFIED DRUG; ALPHA-BUNGAROTOXIN RECEPTOR; AMYLOID BETA PROTEIN (1 28); AMYLOID BETA PROTEIN (1 42); AMYLOID BETA-PROTEIN (1-28); AMYLOID BETA-PROTEIN (1-42); CALCIUM CHANNEL; PEPTIDE FRAGMENT;

ALZHEIMER DISEASE; ANIMAL CELL; ARTICLE; ATOMIC FORCE MICROSCOPY; BRAIN CELL; CELL LEVEL; CELL VIABILITY; CONTROLLED STUDY; CULTURE MEDIUM; ENZYME ACTIVITY; ENZYME ASSAY; MOUSE; NERVE CELL CULTURE; NONHUMAN; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INDUCTION; SENILE PLAQUE; ANIMAL; C57BL MOUSE; CELL CULTURE; CELL SURVIVAL; CYTOLOGY; DRUG EFFECT; ENZYME ACTIVATION; METABOLISM; NERVE CELL;

ANIMALIA; MUS MUSCULUS;

ACETYLCHOLINESTERASE; AMYLOID BETA-PROTEIN; ANIMALS; CALCIUM CHANNEL BLOCKERS; CALCIUM CHANNELS; CELL SURVIVAL; CELLS, CULTURED; CHOLINE; ENZYME ACTIVATION; MICE; MICE, INBRED C57BL; NEURONS; NICOTINIC AGONISTS; NICOTINIC ANTAGONISTS; PEPTIDE FRAGMENTS; RECEPTORS, NICOTINIC;

EID: 1442348421     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.2003.02296.x     Document Type: Article

References (63)

1. Alkondon M., Pereira E. F., Cortes W. S., Maelicke A. and Albuquerque E. X. (1997) Choline is a selective agonist of α7 nicotinic acetylcholine receptors in the rat brain neurons. Eur. J. Neurosci. 9, 2734-2742.
2. Apelt J., Kumar A. and Schliebs R. (2002) Impairment of cholinergic neurotransmission in adult and aged transgenic Tg2576 mouse brain expressing the Swedish mutation of human β-amyloid precursor protein. Brain Res. 953, 17-30.
3. Atack J. R., Perry E. K., Bonham J. R., Perry R. H., Tomlinson B. E., Blessed G. and Fairbaim A. (1983) Molecular forms of acetylcholinesterase in senile dementia of Alzheimer type: selective loss of the intermediate (10S) form. Neurosci. Lett. 40, 199-204.
4. Bednar I., Paterson D., Marutle A. et al. (2002) Selective nicotinic receptor consequences in APP (SWE) transgenic mice. Mol. Cell Neurosci. 20, 354-365.
5. Brashear H. R., Godec M. S. and Carlsen J. (1988) The distribution of neuritic plaques and acetylcholinesterase staining in the amygdala in Alzheimer's disease. Neurology 38, 1694-1699.
6. Brimijoin S. (1983) Molecular forms of acetylcholinesterase in brain, nerve and muscle: nature, localization and dynamics. Prog. Neurobiol. 21, 291-322.
7. Broide R. S. and Leslie F. M. (1999) The α7 nicotinic acetylcholine receptor in neuronal plasticity. Mol. Neurobiol. 20, 1-16.
8. Chavez-Noriega L. E., Crona J. H., Washburn M. S., Urrutia A., Elliott K. J. and Johnson E. C. (1997) Pharmacological characterization of recombinant human neuronal nicotinic acetylcholine receptors hα2β2, hα2β4, hα3β2, hα3β4, hα4β2, hα4β4 and hα4 expressed in Xenopus oocytes. J. Pharmacol. Exp. Ther. 280, 346-356.
9. Cheung N. S., Small D. H. and Livett B. G. (1993) An amyloid peptide, βA4, 25-35, mimics the function of substance P on modulation of nicotine-evoked secretion and desensitization in cultured bovine adrenal chromaffin cells. J. Neurochem. 60, 1163-1166.
10. Dineley K. T., Westerman M., Bui D., Bell K., Hsiao Ashe K. and Sweatt J. D. (2001) β-amyloid activates the mitogen-activated protein kinase cascade via hippocampal α7 nicotinic acetylcholine receptors: in vitro and in vivo mechanisms related to Alzheimer's disease. J. Neurosci. 21, 4125-4133.
11. Dineley K. T., Bell K. A., Bui D. and Sweatt J. D. (2002) β-Amyloid peptide activates α7 nicotinic acetylcholine receptors expressed in Xenopus oocytes. J. Biol. Chem. 277, 25056-25061.
12. Evin G. and Beyreuther K. and Masters C. L. (1994) Alzheimer's disease amyloid precursor protein (Aβ PP): proteolytic processing, secretases and βA4 amyloid production. Amyloid 1, 263-280.
13. Fishman E. B., Siek G. C., MacCallum R. D., Bird E. D., Volicer L. and Marquis J. K. (1986) Distribution of the molecular forms of acetylcholinesterase in human brain: alterations in dementia of the Alzheimer type. Ann. Neurol. 19, 246-252.
14. Fodero L. R., Saez-Valero J., McLean C. A., Martins R. N., Beyreuther K., Masters C. L., Robertson T. A. and Small D. H. (2002) Altered glycosylation of acetylcholinesterase in APP (SW) Tg2576 transgenic mice occurs prior to amyloid plaque deposition. J. Neurochem. 81, 441-448.
15. Friede R. L. (1965) Enzyme histochemical studies of senile plaques. J. Neuropathol. Exp. Neurol. 24, 477-491.
16. Fuller S. J., Storey E., Li Q. X., Smith A. I., Beyreuther K. and Masters C. L. (1995) Intracellular production of βA4 amyloid of Alzheimer's disease: modulation by phosphoramidon and lack of coupling to the secretion of the amyloid precursor protein. Biochemistry 34, 8091-8098.
17. Gerzanich V., Peng X., Wang F., Wells G., Anand R., Fletcher S. and Lindstrom J. (1995) Comparative pharmacology of epibatidine: a potent agonist for neuronal nicotinic acetylcholine receptors. Mol. Pharmacol. 48, 774-782.
18. Geula C. and Mesulam M. (1989) Special properties of cholinesterases in the cerebral cortex of Alzheimer's disease. Brain Res. 498, 185-189.
19. Gomez-Ramos P., Mufson E. J. and Moran M. A. (1992) Ultrastructural localization of acetylcholinesterase in neurofibrillary tangles, neuropil threads and senile plaques in aged and Alzheimer's brain. Brain Res. 569, 229-237.
20. Grassi F., Palma E., Tonini R., Amici M., Ballivet M. and Eusebi F. (2003) Amyloid β(1-42) peptide alters the gating of human and mouse alpha-bungarotoxin-sensitive nicotinic receptors. J. Physiol. 547, 147-157.
21. Grisaru D., Stemfeld M., Eldor A., Glick D. and Soreq H. (1999) Structural roles of acetylcholinesterase variants in biology and pathology. Eur. J. Biochem. 264, 672-686.
22. Herrero C. J., García-Palomero E., Pintado A. J., García A. G. and Montiel C. (1999) Differential blockade of rat α3β4 and α7 neuronal nicotinic receptors by ω-conotoxin MVIIC, ω-conotoxin GVIA and diltiazem. Br. J. Pharmacol. 127, 1375-1387.
23. Ida N., Hartmann T., Pantel J., Schröder J., Zerfass R., Förstl H., Sandbrink R., Masters C. L. and Beyreuther K. (1996) Analysis of heterogeneous βA4 peptides in human cerebrospinal fluid and blood by a newly developed sensitive western blot assay. J. Biol. Chem. 271, 22908-22914.
24. 1-42. J. Neurobiol. 55, 25-30.
25. Liu Q., Kawai H. and Berg D. K. (2001) β-Amyloid peptide blocks the response of α7-containing nicotinic receptors on hippocampal neurons. Proc. Natl Acad. Sci. USA 98, 4734-4739.
26. Lopez M. G., Montiel C., Herrero C. J. et al. (1998) Unmasking the functions of the chromaffin cell α7 nicotinic receptor by using short pulses of acetylcholine and selective blockers. Proc. Natl Acad. Sci. USA 95, 14184-14189.
27. Luo Z. D., Fuentes M. E. and Taylor P. (1994) Regulation of acetylcholinesterase mRNA stability by calcium during differentiation from myoblasts to myotubes. J. Biol. Chem. 269, 27216-27223.
28. Luo Z. D., Pincon-Raymond M. and Taylor P. (1996) Acetylcholinesterase and nicotinic acetylcholine receptor expression diverge in muscular dysgenic mice lacking the L-type calcium channel. J. Neurochem. 67, 111-118.
29. Luo Z. D., Wang Y., Werlen G., Camp S., Chien K. R. and Taylor P. (1999) Calcineurin enhances acetylcholinesterase mRNA stability during C2-C3 muscle cell differentiation. Mol. Pharmacol. 56, 886-894.
30. Massoulié J., Pezzementi L., Bon S., Krejci E. and Vallette F. M. (1993) Molecular and cellular biology of cholinesterases. Prog. Neurobiol. 41, 31-91.
31. Masters C. L., Simms G., Weinman N. A., Multhaup G., McDonald B. L. and Beyreuther K. (1985) Amyloid plaque core protein in Alzheimer's disease and Down's syndrome. Proc. Natl. Acad. Sci. USA 82, 4245-4249XX.
32. Melo J. B., Agostinho P. and Oliveira C. R. (2003) Involvement of oxidative stress in the enhancement of acetylcholinesterase activity induced by amyloid β-peptide. Neurosci. Res. 45, 117-127.
33. Mesulam M. M. (1986) Alzheimer plaques and cortical cholinergic innervation. Neuroscience 17, 275-276.
34. Mesulam M. M. and Geula C. (1988) Acetylcholinesterase-rich pyramidal neurons in the human neocortex and hippocampus: absence at birth, development during the life span, and dissolution in Alzheimer's disease. Ann. Neurol. 24, 765-773.
35. Mok S. S., Turner B. J., Beyreuther K., Masters C. L., Barrow C. J. and Small D. H. (2002) Toxicity of substrate-bound amyloid peptides on vascular smooth muscle cells is enhanced by homocysteine. Eur. J. Biochem. 269, 3014-3022.
36. Papke R. L., Bencherif M. and Lippiello P. (1996) An evaluation of neuronal nicotinic acetylcholine receptor activation by quaternary nitrogen compounds indicates that choline is selective for the α7 subtype. Neurosci. Lett. 213, 201-204.
37. Perry E. K. (1980) The cholinergic system in old age and Alzheimer's disease. Age Ageing 9, 1-8.
38. Perry E. K., Morris C. M., Court J. A., Cheng A., Fairbaim A. F., McKeith I. G., Irving D., Brown A. and Perry R. H. (1995) Alteration in nicotine binding sites in Parkinson's disease, Lewy body dementia and Alzheimer's disease: possible index of early neuropathology. Neuroscience 64, 385-395.
39. Perry E. K., Martin-Ruiz C., Lee M. et al. (2000) Nicotinic receptor subtypes in human brain ageing, Alzheimer and Lewy body diseases. Eur. J. Pharmacol. 393, 215-222.
40. Pettit D. L., Shao Z. and Yakel J. L. (2001) β-Amyloid (1-42) peptide directly modulates nicotinic receptors in the rat hippocampal slice. J. Neurosci. 21, RC120.
41. Postuma R. B., He W., Nunan J., Beyreuther K., Masters C. L., Barrow C. J. and Small D. H. (2000) Substrate-bound β-amyloid peptides inhibit cell adhesion and neurite outgrowth in primary neuronal cultures. J. Neurochem. 74, 1122-1130.
42. Sáez-Valero J. and Small D. H. (2001) Altered glycosylation of cerebrospinal fluid butyrylcholinesterase in Alzheimer's disease. Brain Res. 889, 247-250.
43. Sáez-Valero J., Sbema G., McLean C. A., Masters C. L. and Small D. H. (1997) Glycosylation of acetylcholinesterase as diagnostic marker for Alzheimer's disease. Lancet 350, 929.
44. Sáez-Valero J., Sbema G., McLean C. A. and Small D. H. (1999) Molecular isoform distribution and glycosylation of acetylcholinesterase are altered in brain and cerebrospinal fluid of patients with Alzheimer's disease. J. Neurochem. 72, 1600-1608.
45. Sáez-Valero J., Barquero M. S., Marcos A., McLean C. A. and Small D. H. (2000) Altered glycosylation of acetylcholinesterase in lumbar cerebrospinal fluid of patients with Alzheimer's disease. J. Neurol. Neurosurg. Psychiatry 69, 664-667.
46. Sáez-Valero J., Fodero L. R., White A. R., Barrow C. J. and Small D. H. (2003) Acetylcholinesterase is increased in mouse neuronal and astrocyte cultures are treatment with β-amyloid peptides. Brain Res. 965, 283-286.
47. Sbema G., Saez-Valero J., Beyreuther K., Masters C. L. and Small D. H. (1997) The amyloid β-protein of Alzheimer's disease increases acetylcholinesterase expression by increasing intracellular calcium in embryonal carcinoma P19 cells. J. Neurochem. 69, 1177-1184.
48. Sbema G., Saez-Valero J., Li Q. X., Czech C., Beyreuther K. and Masters C. L., McLean C. A. and Small D. H. (1998) Acetylcholinesterase is increased in the brains of transgenic mice expressing the C-terminal fragment (CT100) of the β-amyloid protein precursor of Alzheimer's disease. J. Neurochem. 71, 723-731.
49. Selkoe D. J. (1994) Normal and abnormal biology of the β-amyloid precursor protein. Annu. Rev. Neurosci. 17, 489-517.
50. Small D. H., Michaelson S. and Sbema G. (1996) Non-classical actions of cholinesterases: role in cellular differentiation, tumorigenesis and Alzheimer's disease. Neurochem. Int. 28, 453-483.
51. Small D. H., Mok S. S. and Bornstein J. C. (2001) Alzheimer's disease and Aβ toxicity: from top to bottom. Nat. Rev. Neurosci. 2, 595-598.
52. Smith P. K., Krohn R. I., Hermanson G. T. et al. (1985) Measurement of protein using bicinchoninic acid. Anal. Biochem. 150, 76-85.
53. Soto C., Branes M. C., Alvarez J. and Inestrosa N. C. (1994) Structural determinants of the Alzheimer's amyloid β-peptide. J. Neurochem. 63, 1191-1198.
54. Taylor P. and Radic Z. (1994) The cholinesterases: from genes to proteins. Annu. Rev. Pharmacol. Toxicol. 34, 281-320.
55. Tozaki H., Matsumoto A., Kanno T., Nagai K., Nagata T., Yamamoto S. and Nishizaki T. (2002) The inhibitory and facilitatory actions of amyloid-β peptides on nicotinic ACh receptors and AMPA receptors. Biochem. Biophys. Res. Commun. 294, 42-45.
56. 2+ channels of chromaffin cells. Eur. J. Pharmacol. 320, 249-257.
57. Wang H.-Y., Lee D. H. S., Davis C. B. and Shank R. P. (2000a) Amyloid peptide Aβ(1-42) binds selectively and with picomolar affinity to α7 nicotinic acetylcholine receptors. J. Neurochem. 75, 1155-1161.
58. Wang H.-Y., Li W., Benedetti N. J. and Lee D. H. S. (2003) α7 nicotinic acetylcholine receptors mediate β-amyloid peptides-induced tau protein phosphorylation. J. Biol. Chem. 278, 31547-31553.
59. 1-42 binds to α7 nicotinic acetylcholine receptor with high affinity: implications for Alzheimer's disease pathology. J. Biol. Chem. 275, 5626-5632.
60. Ward J. M., Cockcroft V. B., Lunt G. G., Smillie F. S. and Wonnacott S. (1990) Methyllycaconitine: a selective probe for neuronal α-bungarotoxin binding sites. FEBS Lett. 270, 45-48.
61. Wevers A., Monteggia L., Nowacki S. et al. (1999) Expression of nicotinic acetylcholine receptor subunits in the cerebral cortex in Alzheimer's disease: histotopographical correlation with amyloid plaques and hyperphosphorylated-tau protein. Eur. J. Neurosci. 11, 2551-2565.
62. White A. R., Multhaup G., Maher F., Bellingham S., Camakaris J., Zheng H., Bush A. I., Beyreuther K., Masters C. L. and Cappai R. (1999) The Alzheimer's disease amyloid precursor protein modulates copper-induced toxicity and oxidative stress in primary neuronal cultures. J. Neurosci. 19, 9170-9179.
63. Xiao Y., Meyer E. L., Thompson J. M., Surin A., Wroblewski J. and Kellar K. J. (1998) Rat α3/β4 subtype of neuronal nicotinic acetylcholine receptor stably expressed in a transfected cell line: pharmacology of ligand binding and function. Mol. Pharmacol. 54, 322-333.